Spine News and Research

RSS

FDA clears DFine's new percutaneous radiofrequency ablation device for metastatic spinal lesions

DFine, Inc., developer of minimally invasive solutions for the treatment of vertebral pathologies, announced today the 510(k) clearance of a new platform extension indicated for the palliative treatment of cancer patients. The product, a percutaneous radiofrequency ablation (RFA) device, provides localized tumor necrosis of vertebral body lesions where metastatic disease has spread to the spine causing severe pain and discomfort.

4 Oct 2010

FDA approves NovaBone Putty MIS Delivery System for orthopedic surgery

NovaBone Products, a medical device company, today announces the U.S. Food and Drug Administration's (FDA) approval of the NovaBone Putty® MIS Delivery System designed for use in minimally invasive orthopedic procedures.

4 Oct 2010

Integra LifeSciences launches EGR system in the U.S.

Integra LifeSciences Holdings Corporation announced today the launch of the Integra™ Endoscopic Gastroc Release (EGR) System in the United States. Integra's EGR System is a disposable device with a unique articulating blade that allows selective cutting of soft tissues. It is intended for use in the surgical treatment for posterior heel cord, or equinus, contracture.

4 Oct 2010

IRSF awards $1.5M in research grants for Rett syndrome treatment

The International Rett Syndrome Foundation (IRSF) announced today that it will award an additional $1.5M in research grants, bringing the 2010 total to $2.15 million for innovative basic and translational research that moves treatments for Rett syndrome a step closer to the clinic.

4 Oct 2010

Collagen Matrix's new Collagen Dental Membrane granted FDA 510(k) clearance

Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it has received FDA's 510(k) clearance of a new Collagen Dental Membrane derived from porcine dermis indicated for use in oral surgical procedures involving guided tissue and bone regeneration.

1 Oct 2010

K2M launches VIKOS Cervical Allograft System

K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the launch of its first product in the spinal biologics market, the VIKOS™ Cervical Allograft System. K2M worked with LifeNet Health™, a leading allograft bio-implant and regenerative medicine company, to combine quality machined allograft implants with precision instrumentation.

1 Oct 2010

Neb. insurer launches pilot program to cut costs, improve health; W.Va. Medicaid official defends no-bid contract

Lincoln Journal Star: Blue Cross and Blue Shield of Nebraska, the state's largest health insurer, is establishing a new pilot program that seeks to give doctors better patient information so that they can deal more effectively with patients' needs and help lower costs. The pilot will use a web-based program that officials hope can take disparate medical records and produce "tailored patient checklists" that doctors can use.

1 Oct 2010

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

Wenzel Spine, Inc., a medical device company focused on offering less invasive, stand-alone alternatives to traditional spinal fusion, today announced they have received 510K clearance to market the VariLift Expandable Interbody Fusion System.

30 Sep 2010

The Courts: Doc-owned hospitals protest health law, new Sutter Hospital challenged

Lawyers for doctor-owned hospitals will make the case today that the health law unfairly curbs their business model before a judge in Tyler, Texas, the Austin American-Statesman reports.

30 Sep 2010

Clinical study results for patient-specific vaccine therapy to treat metastatic melanoma announced

Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.

28 Sep 2010

Scientific data, evidence reject vertebroplasty procedure

As a patient safety best practice and endorsement of evidence-based medicine, the American Academy of Orthopaedic Surgeons Board of Directors approved and released a clinical practice guideline, which found a strong recommendation against a popular procedure called vertebroplasty as a way to treat fractures in the spine. Clinical practice guidelines are one avenue the Academy uses to ensure that patients receive high quality care.

28 Sep 2010

Bayer’s new oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved a new oral contraceptive, Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).

28 Sep 2010

FDA grants ArthroCare marketing clearance for Parallax Contour Vertebral Augmentation Device

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Parallax® Contour® Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures.

24 Sep 2010

Vision-Sciences, Stryker sign urology supply agreement

Vision-Sciences, Inc. announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation, through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes.

From Stryker 23 Sep 2010

Raltegravir could be valid target against all Herpesviridae

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, have published a new study that demonstrates that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus.

23 Sep 2010

Revolutionary technology 'cooks' brain tumor

University Hospitals (UH) Case Medical Center is offering new hope for patients with inoperable brain tumors or lesions previously diagnosed as untreatable through a revolutionary technology called AutoLITT which "cooks" brain tumors with an MRI-guided laser. UH becomes one of only three medical centers in the world offering AutoLITT as part of its arsenal in the fight against cancer. It is especially effective in treating glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.

23 Sep 2010

Mother’s miracle surgery for cancer - body cut in half

Janis Ollson, 31 became the first patient to survive a rare bone cancer which required her body to be cut in half. When she was pregnant with her second child doctors assumed her intense back pain was just a typical symptom of pregnancy. But soon she was diagnosed with a bone cancer called sarcoma that was untreatable by chemotherapy or radiation.

23 Sep 2010

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.

22 Sep 2010

First in-human study of robotically assisted percutaneous coronary intervention system presented at 22nd TCT

The first in-human study of a robotically assisted percutaneous coronary intervention system demonstrated that the technique was safe and feasible. The results of the study were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

22 Sep 2010

New, easy-to-use system puts 'Radiology in the palm of your hand'

Physicians now have access to real time radiology services virtually anywhere, anytime. The new Virtual Viewbox- (patent pending) is a portable interface system that delivers images, electronic medical records (EMR), and specialist consultation to physicians using any internet-ready device.

22 Sep 2010

Spine News and Research

FDA clears DFine's new percutaneous radiofrequency ablation device for metastatic spinal lesions

FDA approves NovaBone Putty MIS Delivery System for orthopedic surgery

Integra LifeSciences launches EGR system in the U.S.

IRSF awards $1.5M in research grants for Rett syndrome treatment

Collagen Matrix's new Collagen Dental Membrane granted FDA 510(k) clearance

K2M launches VIKOS Cervical Allograft System

Neb. insurer launches pilot program to cut costs, improve health; W.Va. Medicaid official defends no-bid contract

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

The Courts: Doc-owned hospitals protest health law, new Sutter Hospital challenged

Clinical study results for patient-specific vaccine therapy to treat metastatic melanoma announced

Scientific data, evidence reject vertebroplasty procedure

Bayer’s new oral contraceptive receives FDA approval

FDA grants ArthroCare marketing clearance for Parallax Contour Vertebral Augmentation Device

Vision-Sciences, Stryker sign urology supply agreement

Raltegravir could be valid target against all Herpesviridae

Revolutionary technology 'cooks' brain tumor

Mother’s miracle surgery for cancer - body cut in half

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

First in-human study of robotically assisted percutaneous coronary intervention system presented at 22nd TCT

New, easy-to-use system puts 'Radiology in the palm of your hand'

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News